UNSPSC 41202018: Echovirus serological reagents

In this classification, Echovirus serological reagents are devices used in test to identify specific Echovirus antibodies in serum. US FDA regulates Echovirus serological reagents under 21 CFR 866.3205 and under FDA product code GNL.

UNSPSC 41202018 Echovilus serological reagents (Commodity) shows minimal recent state and local procurement activity directly aligned with the code's abstract scope. The recent opportunities blocks contain two HIV/Syphilis reagent procurements by the Illinois Department of Public Health (emergency sole-source purchases from Abbott Laboratories in February and May 2026), an HIV test kit procurement by the City of Austin (IFB for Abbott Determine kits due July 17, 2026), and a multi-analyte screening contract by the Illinois Department of Public Health for Hepatitis/HIV/Syphilis assays (IFB due March 16, 2026). However, the remaining opportunities in the block—offender drug testing services by Collin County, forensic analysis by Texas Department of Criminal Justice, pool maintenance by Collier County, and clinical diagnostic laboratory services by University of Houston—are unrelated to echovirus serology or viral diagnostic reagents. The code does not appear to be the primary vehicle for state and local purchasing in this category.

Activity confirmed to align with the code appears limited to Illinois and Texas. The Illinois Department of Public Health conducted two emergency procurements for Abbott HIV and Syphilis reagents (totaling $38,079.50 across the February and May 2026 sole-source awards) and issued a competitive IFB in February 2026 for a five-year Hepatitis/HIV/Syphilis multi-analyte screening contract (bid due March 16, 2026) with estimated annual volumes of 13,200 HIV tests, 11,000 Syphilis tests, 3,300 Hepatitis B tests, and 3,000 Hepatitis C tests. The City of Austin posted an IFB on June 15, 2026 (due July 17, 2026) for Abbott Determine HIV 1/2 test kits in support of Austin Public Health Program. Procurement specialists indicated are Alejandro Arroyo at Austin and Mike Caceres at Illinois Department of Public Health. The code shows episodic rather than sustained activity among state and local buyers, and the match between the nominal code name and actual recent solicitation activity is indirect—HIV and Syphilis reagents dominate, while echovirus serology purchases do not surface in the recent opportunity list.